Beginner Guide

Complete Starter Guide to GLP-1: Your First 30 Days

GLP-1 Companion · 9 min read

The first month on a GLP-1 receptor agonist is unlike any other phase of the treatment. Your body is adjusting to a novel mechanism — slowed gastric emptying, heightened satiety signaling, and altered glucose metabolism — while you are simultaneously building new habits. Knowing what to expect week by week takes the mystery out of the process and helps you stay the course when results seem slower than you hoped.

Week 1: Side Effects Begin, Appetite Starts to Quiet

The first week is primarily about tolerating the medication, not losing weight. Starting doses are intentionally conservative — semaglutide (Ozempic/Wegovy) begins at 0.25 mg weekly and tirzepatide (Mounjaro/Zepbound) at 2.5 mg weekly. These doses are below the therapeutic threshold for weight loss; their purpose is to acclimate your digestive system. Expect some combination of mild nausea, reduced appetite, fatigue, and occasional loose stools. These symptoms are most intense in the first 24 to 48 hours after the injection and then taper.

• Eat small, bland, low-fat meals during the first several days
• Stay well hydrated — dehydration worsens nausea
• Avoid alcohol and very spicy or fatty foods
• Rest if fatigue is significant; this is temporary
• Do not expect visible weight changes yet

Weeks 2 to 3: Appetite Starts to Change

By the second and third weeks, most patients notice a genuine shift in hunger patterns. The relentless food noise — the background preoccupation with eating, snacking, and anticipating the next meal — begins to quiet. Portions that used to feel necessary now feel like too much. This is one of the most remarkable early effects of GLP-1 therapy and represents the medication doing exactly what it is designed to do. Lean into it by reinforcing the behaviors you want to build: eating slowly, stopping when satisfied rather than full, and choosing protein-forward meals.

Week 4: The First Dose Increase

After four weeks at the starting dose, most GLP-1 protocols move to the next dose level. For semaglutide, this means increasing from 0.25 mg to 0.5 mg. For tirzepatide, from 2.5 mg to 5 mg. This first escalation sometimes brings a temporary return of nausea and GI symptoms, similar to (but often milder than) week one. Knowing this in advance prevents discouragement. The same dietary strategies that worked in week one apply here.

Nutrition Setup: Protein Targets and Meal Sizing

GLP-1 therapy significantly reduces caloric intake by suppressing appetite, but the quality of the calories you do eat matters enormously. The primary nutritional priority is protein. Adequate protein intake — typically 0.7 to 1 gram per pound of goal body weight daily — preserves lean muscle mass as you lose weight. Without sufficient protein, a meaningful portion of the weight you lose will be muscle rather than fat, which undermines metabolic health and long-term outcomes.

• Prioritize protein at every meal: eggs, Greek yogurt, cottage cheese, chicken, fish, legumes
• Target at least 20 to 30 grams of protein per meal
• Eat smaller portions overall — your stomach empties more slowly on GLP-1 therapy
• Avoid using reduced appetite as a reason to skip meals entirely; inadequate nutrition leads to muscle loss
• Keep easy high-protein snacks on hand for days when appetite is especially suppressed

Exercise Starting Point: Building the Habit Early

The research is clear that exercise combined with GLP-1 therapy produces better fat loss, greater muscle preservation, and improved cardiovascular outcomes compared to medication alone. You do not need to begin an intense workout program in week one — in fact, attempting too much while managing side effects often leads to burnout. Instead, aim to establish a consistent, sustainable movement habit. Walking 20 to 30 minutes daily is an excellent foundation. Add resistance training (weights or bodyweight exercises) at least twice per week as tolerated, as this is the most effective tool for preserving muscle mass during caloric restriction.

What to Track During Your First Month

Tracking a few key metrics gives you an objective picture of progress and catches problems early.

• Body weight (weekly, same day and time, ideally morning after bathroom)
• Waist circumference (every two weeks — sometimes this drops before the scale moves)
• Protein intake (at least loosely, to ensure you are meeting targets)
• Injection log: date, site used, any side effects noted
• Energy levels and sleep quality (GLP-1 can affect both)
• Blood glucose if you have diabetes or prediabetes

Medication Management Routine

GLP-1 receptor agonists are weekly injections, so building a consistent injection day and time prevents missed doses. Choose a day that works logistically and socially — many people choose a day when they can rest if needed (a Friday or Saturday). Set a recurring weekly phone reminder. Store your pen in the refrigerator, clearly marked so household members do not mistake it for something else. Prepare a travel kit if you have trips planned: a small insulated bag with ice packs keeps the pen at the right temperature for up to 24 hours.

Warning Signs That Require Prescriber Contact

Most GLP-1 side effects are mild and self-limiting. However, certain symptoms require prompt medical attention.

• Severe abdominal pain, especially pain that radiates to the back — potential pancreatitis
• Vomiting that prevents you from keeping liquids down for more than 24 hours
• Signs of significant dehydration: dizziness, rapid heartbeat, dark urine
• Vision changes (relevant for patients managing diabetes)
• Swelling or pain in the neck or a new lump — a rare but flagged risk for thyroid tumors
• Symptoms of low blood sugar if you are also on insulin or a sulfonylurea

Mental Preparation for Slow Initial Weight Loss

Social media content about GLP-1 therapy is heavily skewed toward outlier results — the person who lost 15 pounds in the first month, the dramatic before-and-after at 6 weeks. These are not representative of the typical experience. Most clinical trial participants saw their most significant weight loss between months 3 and 12, as doses escalated to therapeutic levels. The first month is about tolerating the medication, building habits, and letting the biology work. Comparing your week-four scale reading to someone else's six-month transformation is not useful.

Community Support and Resources

Connecting with others who are on the same journey provides accountability, practical tips, and reassurance on hard days. Online communities for GLP-1 users exist across multiple platforms and are generally highly supportive. Your prescribing clinic may also offer check-in calls or group sessions. If you are working with an obesity medicine specialist, ask about their patient support resources. You do not have to navigate the first 30 days alone.

The first 30 days on GLP-1 therapy are a foundation, not a finish line. The patients who build good habits — consistent protein intake, regular movement, weekly tracking — in the first month consistently report better long-term outcomes than those who rely on the medication alone.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Jastreboff et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.